- Home
- NORD vs DAVA Comparison
NORD vs DAVA Comparison
Compare NORD & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NORD | DAVA |
|---|---|---|
| Founded | 1993 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Professional Services | EDP Services |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 95.5M | 108.3M |
| IPO Year | 2005 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NORD | DAVA |
|---|---|---|
| Price | $3.69 | $1.62 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $3.68 |
| AVG Volume (30 Days) | N/A | ★ 216.7K |
| Earning Date | 07-25-2017 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,346.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.70 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | N/A | $1.52 |
| 52 Week High | N/A | $9.47 |
Technical Indicators
Market Signals| Indicator | NORD | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 30.51 |
| Support Level | N/A | $1.60 |
| Resistance Level | N/A | $3.11 |
| Average True Range (ATR) | 0.00 | 0.13 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 13.10 |
Price Performance
Historical ComparisonAbout NORD Nordicus Partners Corporation Common Stock
Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.